About Roche CDx

Advancing precision medicine through diagnostics for more than a decade

In collaboration with leading pharmaceutical companies, we identify and develop innovative predictive diagnostics to target those patients who are more likely to respond to specific therapies.

The global partner of choice for companion diagnostics, we help to advance personalized healthcare by delivering diagnostic confidence through a broad menu of high medical value predictive assays. Our standardized, fully-automated and easy-to-use solutions enable rapid turnaround time and reliable results, empowering physicians to make the right patient decisions more quickly.

Integrated, end-to-end solution

We offer a full, end-to-end development solution with a clear path to IVD – from DISCOVERY research products and biomarker hypothesis testing to global commercialization.

Commercial strength

With the largest global footprint of IHC/ISH staining systems and unrivaled affiliate sales network, our tests are in the most labs – and impact the most patients – worldwide.

Rigorous development discipline

Our deliberate, proven assay development methods, experienced regulatory perspectives and track record of success deliver reliable results and earn trust with our partners.

CDx development & co-launch strategy

We understand what it takes to bring an IVD to market and that launching a CDx requires unique expertise. From exploratory research through global commercialization, we offer a broad range of activities and solutions to support successful development and registration of your assay.

We can help position you for success by developing a solid framework for your diagnostic strategy and ensuring all critical resources for planning and execution of a global launch strategy are in place.

EARLY STAGE DEVELOPMENT

LATE STAGE DEVELOPMENT

LAUNCH & COMMERCIALIZATION

CDx DEVELOPMENT PROCESS

ASSAY PORTFOLIO